The estimated Net Worth of Jose Carlos Gutierrez Ramos is at least $2.45 Milion dollars as of 21 August 2023. Dr Ramos owns over 590 units of Danaher stock worth over $1,887,269 and over the last 9 years he sold DHR stock worth over $562,533.
Sign up
Dr D DHR stock SEC Form 4 insiders trading
Dr has made over 6 trades of the Danaher stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 590 units of DHR stock worth $147,819 on 21 August 2023.
The largest trade he's ever made was selling 10,090 units of Danaher stock on 21 January 2020 worth over $293,619. On average, Dr trades about 1,009 units every 61 days since 2016. As of 21 August 2023 he still owns at least 6,939 units of Danaher stock.
You can see the complete history of Dr Ramos stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. biography
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. is the Sr. VP & Chief Science Officer at Danaher.
How old is Dr D?
Dr D is 57, he's been the Sr. VP & Chief Science Officer of Danaher since . There are 9 older and 15 younger executives at Danaher. The oldest executive at Danaher Corp. is John Schwieters, 80, who is the Independent Director.
What's Dr D's mailing address?
Jose's mailing address filed with the SEC is 2200 PENNSYLVANIA AVENUE NW, SUITE 800W, WASHINGTON, DC, 20037.
Insiders trading at Danaher
Over the last 20 years, insiders at Danaher have traded over $2,183,160,204 worth of Danaher stock and bought 226,618 units worth $34,863,916 . The most active insiders traders include Steven M Rales, Mitchell P Rales a Robert J Hugin. On average, Danaher executives and independent directors trade stock every 14 days with the average trade being worth of $25,840,276. The most recent stock trade was executed by Georgeann Couchara on 26 August 2024, trading 952 units of DHR stock currently worth $255,488.
What does Danaher do?
Danaher Corporation is an American globally diversified conglomerate founded by brothers Stephen and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.
What does Danaher's logo look like?
Complete history of Dr Ramos stock trades at Momenta Pharmaceuticals, Danaher, Synlogic Inc, Evelo Biosciences Inc a Bicycle Therapeutics plc
Danaher executives and stock owners
Danaher executives and other stock owners filed with the SEC include:
-
Rainer Blair,
President, Chief Executive Officer, Director -
Daniel Comas,
Executive Vice President -
Joakim Weidemanis,
Executive Vice President -
Matthew McGrew,
Chief Financial Officer, Executive Vice President -
Angela Lalor,
Senior Vice President - Human Resources -
Rainer M. Blair,
Pres, CEO & Director -
Brian Ellis,
Senior Vice President, Chief Compliance Officer, General Counsel -
Angela S. Lalor,
Sr. VP of HR -
Joakim Weidemanis,
Exec. VP -
Matthew R. McGrew,
CFO & Exec. VP -
Brian W. Ellis,
Sr. VP, Gen. Counsel & Chief Compliance Officer -
John Schwieters,
Independent Director -
Elias Zerhouni,
Independent Director -
Linda Hefner Filler,
Lead Independent Director -
Walter Lohr,
Independent Director -
Raymond Stevens,
Independent Director -
Alan Spoon,
Independent Director -
Teri List-Stoll,
Independent Director -
Pardis Sabeti,
Independent Director -
Jessica Mega,
Independent Director -
Mitchell P. Rales,
Co-Founder & Director -
Steven M. Rales,
Co-Founder & Chairman -
Mitchell Rales,
Director -
Daniel Raskas,
Senior Vice President - Corporate Development -
William King,
Senior Vice President - Strategic Development -
Robert Lutz,
Senior Vice President, Chief Accounting Officer -
Steven Rales,
Chairman of the Board -
Matthew E. Gugino C.F.A., CPA,
VP of Investor Relations and FP&A -
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.,
Sr. VP & Chief Science Officer -
Christopher M. Bouda,
Chief Accounting Officer -
Teri List,
Director -
Robert J Hugin,
Director -
Donald J Ehrlich,
Director -
William K Daniel,
EVP -
Thomas Patrick Jr Joyce,
President and CEO -
Christopher Paul Riley,
Executive Vice President -
Jonathan P Graham,
Senior VP & GC -
Montgomery Julie A Sawyer,
Executive Vice President -
H Lawrence Jr Culp,
President and CEO -
Philip Knisely,
Executive Vice President -
Mortimer M Caplin,
Director -
A Emmet Jr Stephenson,
Director -
James H Ditkoff,
Senior VP-Tax & Finance -
Steve Simms,
Executive Vice President -
Patrick W Allender,
Executive VP -
Daniel A Pryor,
VP-Strategic Development -
Mark A Beck,
Executive Vice President -
James A Lico,
Executive Vice President -
Georgeann Couchara,
SVP, Human Resources -
Feroz Dewan,
Director -
Jennifer Honeycutt,
Executive Vice President -
A Shane Sanders,
Director -
Christopher Bouda,
VP, Chief Accounting Officer -
Jose Carlos Gutierrez Ramos,
SVP, Chief Science Officer